Keywords: Novo Nordisk, Fourth-quarter and full-year, Financial results

Novo Nordisk 2012 net profit leaps 25% and sales rise 18%

Article | 31 January 2013

Print This

Denmark-based insulin giant Novo Nordisk (NOV: N) saw its shares rise 1.6% to 1,037 kroner in early trading this morning, when the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in